Dietary supplements for obesity
- PMID: 36479472
- PMCID: PMC9710396
- DOI: 10.15167/2421-4248/jpmh2022.63.2S3.2757
Dietary supplements for obesity
Abstract
Obesity and associated complications including diabetes, cardiometabolic dysfunction, disability, malignancy and premature mortality are considered epidemic. Research on obesity is therefore of worldwide importance. The development of obesity is a multifactorial phenomenon with contributions from biological, behavioral, genetic and environmental factors. Obesity and its associated issues require various lifestyle modifications and treatment options such medication, exercise, diet, surgery, pharmacological therapy and dietary supplements. Dietary supplements are considered an attractive alternative to traditional therapy due to their low toxicity profile and their accessibility to the general population. Dietary supplements may include one or more dietary ingredients. In this narrative review, we analyze the effects on obesity and obesity-related issues of various natural components. For example, there are a myriad of supplements that have been used as dietary supplements for weight loss such as minerals, vitamins, amino acids, metabolites, herbs, and plant extracts. This narrative review aims to present the benefits and side-effects of several ingredients of dietary supplements for weight loss and treatment of obesity. In particular, the mechanism of action, results of clinical trials, and possible side effects will be presented for the following ingredients: β-Glucans, bitter orange, calcium, vitamin D, chitosan, chromium, cocoa, coleus forskohlii, conjugate linoleic acid, ephedra sinica, fucoxanthin, garcinia cambogia, glucomannan, green coffee, green tea, guar gum, raspberry, hoodia gordonii, irvingia gabonensis, phenylpropylamine, pyruvate, white kidney bean.
Keywords: Dietary supplements; Nutritional disease; Obesity; Weight loss.
©2022 Pacini Editore SRL, Pisa, Italy.
References
-
- Oppert JM. Obesity: Epidemiology, Pathophysiology and Extra-Respiratory Complications. Rev Pneumol Clin 2002;58:63-70. - PubMed
-
- Vettori A, Paolacci S, Maltese PE, Herbst KL, Cestari M, Michelini S, Michelini S, Samaja M, Bertelli M. Genetic determinants of the effects of training on muscle and adipose tissue homeostasis in obesity associated with lymphedema. Lymphat Res Biol 2021;19:322-33. https://doi.org/10.1089/lrb.2020.0057 10.1089/lrb.2020.0057 - DOI - PubMed
-
- Vettori A, Pompucci G, Paolini B, del Ciondolo I, Bressan S, Dundar M, Kenanoğlu S, Unfer V, Bertelli M. Geneob Project genetic background, nutrition and obesity: a review. Eur Rev Med Pharmacol Sci 2019;23:1751-61. https://doi.org/10.26355/eurrev_201902_17137 10.26355/eurrev_201902_17137 - DOI - PubMed
-
- Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser 2000;894:1-253. - PubMed
-
- Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M, Fanin E, Andrighetto G, Federspil G, Vettor R. Increased serum resistin in adults with Prader-Willi Syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005;90:4335-40. https://doi.org/10.1210/jc.2005-0293 10.1210/jc.2005-0293 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical